Joshua A Englert

Ohio State University

$4,372,842

Attributed

$4,372,842

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $601.5K · FY2013–25

$1M$750K$500K$250K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,372,842 · 3

By mechanism

R01$2,791,533 · 1

K08$997,923 · 1

R56$583,386 · 1

Top collaborators

No co-investigators on record.

Most similar at Ohio State University

Same institution · by research overlap

Ramana V Davuluri$7,215,061
Samson T Jacob$8,333,911
Michael C Ostrowski$13,472,116
Altaf A Wani$12,924,866
Said Sif$3,929,512

Others in their field

Top investigators on “New Therapeutic Target”

David Heimbrook · Leidos Biomedical Research, Inc.$329,975,474
Peter C Adamson · National Childhood Cancer Foundation$269,808,480
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Ralph Parchment · Leidos Biomedical Research, Inc.$153,425,421
Mark S Klempner · Tufts Medical Center$128,021,180
Barbara Driver · Westat, Inc.$126,390,244

Research focus

New Therapeutic TargetLifeTidal VolumeVentilator-Induced Lung InjuryVentilatorPlayInjuryStretchingLung InjuryLungPreventMolecularNovel StrategiesPhysiologyAlveolarCellsMechanical VentilationSepsisClinically RelevantEpithelial CellsIn VivoGeneticComplexInflammation